Results: The total efficiency of the joint use of rabeprazole and mosapride in treating reflux esophagitis is 95.24%, it is significantly higher than that of famotidine Lactulose, and has fe...
英
美
- 結果:雷貝拉唑聯(lián)合莫沙必利組治療反流性食管炎總有效率為95.；24%25；療效顯著(zhù)高于法莫替丁聯(lián)合莫沙必利組；且不良反應少。結論:雷貝拉唑聯(lián)合莫沙必利治療反流性食管炎療效明顯；安全可靠。
